company background image
1066 logo

Shandong Weigao Group Medical Polymer SEHK:1066 Rapporto sulle azioni

Ultimo prezzo

HK$3.98

Cap. di mercato

HK$18.2b

7D

-2.9%

1Y

-48.6%

Aggiornato

02 Sep, 2024

Dati

Dati finanziari dell'azienda +

Shandong Weigao Group Medical Polymer Company Limited

SEHK:1066 Rapporto sulle azioni

Cap. di mercato: HK$18.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

1066 Panoramica delle azioni

Shandong Weigao Group Medical Polymer Company Limited si occupa di ricerca e sviluppo, produzione, vendita all'ingrosso e vendita di dispositivi medici nella Repubblica Popolare Cinese.

1066 analisi fondamentale
Punteggio fiocco di neve
Valutazione6/6
Crescita futura3/6
Prestazioni passate2/6
Salute finanziaria6/6
Dividendi4/6

Shandong Weigao Group Medical Polymer Company Limited Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Shandong Weigao Group Medical Polymer
Prezzi storici delle azioni
Prezzo attuale dell'azioneHK$3.98
Massimo di 52 settimaneHK$8.02
Minimo di 52 settimaneHK$3.60
Beta0.43
1Variazione di 1 mese1.53%
Variazione a 3 mesi-12.91%
Variazione di 1 anno-48.58%
3Variazione a 3 anni-71.53%
Variazione a 5 anni-54.15%
Variazione dall'IPO2,207.25%

Notizie e aggiornamenti recenti

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Aug 30
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Jun 25
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Recent updates

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Aug 30
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Jun 25
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Jun 23
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

May 22
We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Apr 23
Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Mar 17
Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Jan 28
Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Jan 13
Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 17
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Dec 05
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Oct 18
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Oct 06
Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Sep 10
Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Aug 29
Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Jul 09
Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Jun 26
Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Rendimenti per gli azionisti

1066HK Medical EquipmentHK Mercato
7D-2.9%4.4%1.1%
1Y-48.6%-44.0%2.7%

Ritorno vs Industria: 1066 ha avuto una performance inferiore rispetto al Hong Kong Medical Equipment che ha registrato un rendimento -44 % nell'ultimo anno.

Rendimento vs Mercato: 1066 ha avuto una performance inferiore al mercato Hong Kong che ha registrato un rendimento 6.2 % nell'ultimo anno.

Volatilità dei prezzi

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement6.4%
Medical Equipment Industry Average Movement6.8%
Market Average Movement6.3%
10% most volatile stocks in HK Market13.1%
10% least volatile stocks in HK Market3.3%

Prezzo delle azioni stabile: Il prezzo delle azioni di 1066 è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di 1066 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
200012,606Rinan Congwww.weigaogroup.com

Shandong Weigao Group Medical Polymer Company Limited si occupa di ricerca e sviluppo, produzione, vendita all'ingrosso e vendita di dispositivi medici nella Repubblica Popolare Cinese. Opera attraverso i segmenti Prodotti per dispositivi medici, Prodotti ortopedici, Prodotti interventistici, Prodotti per il confezionamento farmaceutico, Prodotti per la gestione del sangue e Altri. L'azienda offre materiali e prodotti medici di consumo monouso, tra cui set per infusione, siringhe, sacche di sangue e segregatori di componenti del sangue, prodotti per il prelievo di sangue, siringhe preriempite per il preconfezionamento di farmaci e aghi medici, che includono principalmente aghi per endovena, aghi per siringa, aghi per catetere endovenoso, aghi per il prelievo di sangue e aghi irregolari; materiali e strumenti ortopedici, tra cui prodotti traumatologici di placche e viti in acciaio, impianti spinali e articolazioni artificiali; materiali e attrezzature per la purificazione del sangue, tra cui aghi per punture, circuiti extracorporei per la purificazione del sangue, dializzatori e relativi materiali di consumo.

Shandong Weigao Group Medical Polymer Company Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Shandong Weigao Group Medical Polymer con la sua capitalizzazione di mercato?
1066 statistiche fondamentali
Capitalizzazione di mercatoHK$18.19b
Guadagni(TTM)HK$2.10b
Ricavi(TTM)HK$14.21b

8.7x

Rapporto P/E

1.3x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
1066 Conto economico (TTM)
RicaviCN¥12.97b
Costo del fatturatoCN¥6.52b
Profitto lordoCN¥6.44b
Altre speseCN¥4.53b
GuadagniCN¥1.91b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)0.42
Margine lordo49.69%
Margine di profitto netto14.74%
Rapporto debito/patrimonio netto16.3%

Come si è comportato 1066 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

4.6%

Rendimento attuale del dividendo

44%

Rapporto di remunerazione
Quando è necessario acquistare 1066 per ricevere un dividendo imminente?
Shandong Weigao Group Medical Polymer date dei dividendi
Data di stacco del dividendoOct 18 2024
Data di pagamento dei dividendiNov 22 2024
Giorni fino al dividendo Ex45 days
Giorni prima della data di pagamento dei dividendi80 days